21 April 2016

BGR-34, the country's first anti-diabetic ayurvedic drug designed for Type-2 diabetes mellitus

Dr. Harsh Vardhan, launched the "CSIR-NBRI Herbarium Online" on the CSIR-NBRI website (www.nbri.res.in), thus making One Hundred Thousand Herbarium collections accessible worldwide. He also released a flyer "CSIR-NBRI HERBARIUM ONLINE" on the occasion.

Dr. Harsh Vardhan specifically directed CSIR-NBRI to take up on an urgent basis the work of scaling up of ‘Herbi Chew’ on a priority basis as a potentially useful product to replace the cancer causing tobacco-based GUTKA currently available in the market. He was very happy to learn about the progress in the development of ‘Muktashree’, a low Arsenic uptake variety of Rice, developed by CSIR-NBRI and Department of Agriculture, West Bengal and envisaged earliest release of this variety for the benefit of citizens living in Arsenic affected areas.
The Minister appreciated the effort of scaling up of CSIR-NBRI and CSIR-CIMAP (Central Institute for Medicinal and Aromatic Plants, Lucknow) joint product BGR-34, the country's first anti-diabetic ayurvedic drug designed for Type-2 diabetes mellitus. He noted that there is an overwhelming response to this drug among Diabetes Type-II patients throughout India.

No comments:

Post a Comment

Featured post

UKPCS2012 FINAL RESULT SAMVEG IAS DEHRADUN

    Heartfelt congratulations to all my dear student .this was outstanding performance .this was possible due to ...